The HBV DNA Viral Load Test measures the amount of Hepatitis B virus DNA in the blood, indicating the level of viral replication and infection severity.

The test is used to confirm active Hepatitis B infection, assess disease severity, monitor treatment response, and guide treatment decisions.

No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or recent health issues.

Results are usually available within 2 to 4 days after the test.

A high viral load indicates a higher quantity of Hepatitis B virus in the blood, suggesting more active infection and potentially greater disease severity.

Recovery time varies; laparoscopic and robotic methods usually involve shorter recovery periods compared to abdominal myomectomy.

ICU Bedside Dialysis is a service provided in the Intensive Care Unit (ICU) for patients with kidney failure who require dialysis while remaining in the ICU for critical care.

Patients may need bedside dialysis if they have acute kidney injury or chronic kidney disease that requires dialysis while they are critically ill or unstable.

Bedside dialysis is performed using specialized equipment and techniques to remove waste products and excess fluids from the blood while the patient remains in the ICU.

Bedside dialysis allows for continuous monitoring and treatment of critically ill patients without needing to transport them to a separate dialysis unit, which can be safer and more convenient.

Risks include infection, bleeding, and complications related to the dialysis procedure. The ICU team closely monitors patients to manage and minimize these risks.